Latest Retail Shareholders News

Page 3 of 11
PYC Therapeutics has successfully closed its retail entitlement offer, raising approximately $47 million at $1.50 per new share with a 40% take-up rate. New shares are set to begin trading on the ASX from 9 March 2026.
Ada Torres
Ada Torres
4 Mar 2026
Brightstar Resources has successfully upsized its Share Purchase Plan to $18 million, raising total equity proceeds of $193 million to fully fund its Goldfields Project and accelerate development at Sandstone.
Maxwell Dee
Maxwell Dee
3 Mar 2026
Adherium Limited has raised $6.7 million through a Placement and Institutional Entitlement Offer, positioning itself to expand its digital respiratory management solutions and advance value-based care contracts with US insurers.
Ada Torres
Ada Torres
18 Feb 2026
29Metals has successfully completed the retail portion of its entitlement offer, raising $31 million and finalising a $150 million capital injection to support its growth ambitions.
Maxwell Dee
Maxwell Dee
17 Feb 2026
TradeWindow has successfully closed its NZ$5.9 million Share Purchase Plan, with retail investors contributing around NZ$217,000. Shares will be allotted at NZ$0.25 each, matching the previous placement price.
Sophie Babbage
Sophie Babbage
17 Feb 2026
Brightstar Resources has launched a $5 million Share Purchase Plan offering eligible shareholders discounted shares to fund key mining projects. The offer opens on 10 February and closes on 27 February 2026.
Maxwell Dee
Maxwell Dee
10 Feb 2026
PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.
Ada Torres
Ada Torres
9 Feb 2026
Kalamazoo Resources has successfully closed an oversubscribed Share Purchase Plan, raising $4.1 million to fast-track drilling and development at its Ashburton Gold Project. Combined with a recent placement, the company secures $12.1 million to advance exploration and pre-feasibility studies.
Maxwell Dee
Maxwell Dee
6 Feb 2026
PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.
Ada Torres
Ada Torres
2 Feb 2026
29Metals Limited has initiated a fully underwritten $150 million entitlement offer at $0.40 per share, aiming to bolster its growth projects and operational recovery following seismic disruptions. The retail offer opens on 28 January and closes on 11 February 2026.
Maxwell Dee
Maxwell Dee
28 Jan 2026
29Metals has successfully closed its institutional entitlement offer, raising approximately $119 million at a notable discount, with a retail offer set to launch later this month. The capital raise aims to fuel key growth projects across its mining portfolio.
Maxwell Dee
Maxwell Dee
21 Jan 2026
EPX Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at $0.25 each, matching a recent institutional placement price. The plan aims to raise up to $700,000 to support the company’s growth and working capital needs.
Sophie Babbage
Sophie Babbage
29 Dec 2025